Updated Warfarin Label Notes Genetics’ Impact On Dosing, But Avoids Recommending Test
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA adds pharmacogenetic information to warfarin label, says more specific recommendations on genetic testing and appropriate dosing await further studies.
You may also be interested in...
FDA Updates Codeine Labeling With Risk Of Morphine Overdose In Breastfed Newborns
Public Health Advisory focuses on risk of morphine overdose in nursing mothers who are “ultra-rapid” metabolizers of codeine.
Rx Misbranding Penalties Should Be Stronger To Stop Counterfeiting, FDA Says
Industry also seems supportive of the idea, while Pew touts the power of the power of track-and-trace as a deterrent.